TY - JOUR
T1 - CCR3 expression and function in asthmatic airway smooth muscle cells
AU - Joubert, Philippe
AU - Lajoie-Kadoch, Stéphane
AU - Labonté, Isabelle
AU - Gounni, Abdelilah Soussi
AU - Maghni, Karim
AU - Wellemans, Vincent
AU - Chakir, Jamila
AU - Laviolette, Michel
AU - Hamid, Qutayba
AU - Lamkhioued, Bouchaib
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2005/8/15
Y1 - 2005/8/15
N2 - Asthma is characterized by an increase in airway smooth muscle mass and a decreased distance between the smooth muscle layer and the epithelium. Furthermore, there is evidence to indicate that airway smooth muscle cells (ASMC) express a wide variety of receptors involved in the immune response. The aims of this study were to examine the expression of CCR3 on ASMC, to compare this expression between asthmatic and nonasthmatic subjects, and to determine the implications of CCR3 expression in the migration of ASMC. We first demonstrated that ASMC constitutively express CCR3 at both mRNA and protein levels. Interestingly, TNF-α increases ASMC surface expression of CCR3 from 33 to 74%. Furthermore, using FACS analysis, we found that ASMC CCR3 is expressed to a greater degree in asthmatic vs control subjects (95 vs 75%). Functionality of the receptor was demonstrated by calcium assay; the addition of CCR3 ligand eotaxin to ASMC resulted in an increase in intracellular calcium production. Interestingly, ASMC was seen to demonstrate a positive chemotactic response to eotaxin. Indeed, ASMC significantly migrated toward 100 ng/ml eotaxin (2.2-fold increase, compared with control). In conclusion, the expression of CCR3 by ASMC is increased in asthmatics, and our data show that a CCR3 ligand such as eotaxin induces migration of ASMC in vitro. These results may suggest that eotaxin could be involved in the increased smooth muscle mass observed in asthmatics through the activation of CCR3.
AB - Asthma is characterized by an increase in airway smooth muscle mass and a decreased distance between the smooth muscle layer and the epithelium. Furthermore, there is evidence to indicate that airway smooth muscle cells (ASMC) express a wide variety of receptors involved in the immune response. The aims of this study were to examine the expression of CCR3 on ASMC, to compare this expression between asthmatic and nonasthmatic subjects, and to determine the implications of CCR3 expression in the migration of ASMC. We first demonstrated that ASMC constitutively express CCR3 at both mRNA and protein levels. Interestingly, TNF-α increases ASMC surface expression of CCR3 from 33 to 74%. Furthermore, using FACS analysis, we found that ASMC CCR3 is expressed to a greater degree in asthmatic vs control subjects (95 vs 75%). Functionality of the receptor was demonstrated by calcium assay; the addition of CCR3 ligand eotaxin to ASMC resulted in an increase in intracellular calcium production. Interestingly, ASMC was seen to demonstrate a positive chemotactic response to eotaxin. Indeed, ASMC significantly migrated toward 100 ng/ml eotaxin (2.2-fold increase, compared with control). In conclusion, the expression of CCR3 by ASMC is increased in asthmatics, and our data show that a CCR3 ligand such as eotaxin induces migration of ASMC in vitro. These results may suggest that eotaxin could be involved in the increased smooth muscle mass observed in asthmatics through the activation of CCR3.
UR - http://www.scopus.com/inward/record.url?scp=23444451466&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=23444451466&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.175.4.2702
DO - 10.4049/jimmunol.175.4.2702
M3 - Article
C2 - 16081847
AN - SCOPUS:23444451466
SN - 0022-1767
VL - 175
SP - 2702
EP - 2708
JO - Journal of Immunology
JF - Journal of Immunology
IS - 4
ER -